Recent studies have confirmed the efficacy of sorafenib for patients with advanced renal cell carcinoma; however, its efficacy and security as an adjuvant therapy in patients with non-metastatic and loco-regional renal cell carcinoma after surgery remains controversial. end result compared between the groups was disease-free survival. Undesirable events were documented to judge the safety of… Continue reading Recent studies have confirmed the efficacy of sorafenib for patients with